Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

• Last SEC data release: 2025-11-14
• Last 15 days FTD volume: A$0.47 M
• Last 3 months FTD volume: A$0.92 M
• Last 12 months FTD volume: A$16.71 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Novavax NVAX	A$15.95 M	A$65.06 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	A$2.8 M	A$17.38 M	🇺🇸 USA
Neurocrine Biosciences NBIX	A$2.71 M	A$30.9 M	🇺🇸 USA
General Electric GE	A$0.13 B	A$0.51 B	🇺🇸 USA
Thermo Fisher Scientific TMO	A$26.73 M	A$78.59 M	🇺🇸 USA
Bristol-Myers Squibb BMY	A$6.09 M	A$0.21 B	🇺🇸 USA
Pfizer PFE	A$24.63 M	A$0.10 B	🇺🇸 USA
Bio-Techne TECH	A$6.32 M	A$14.04 M	🇺🇸 USA
Sangamo Therapeutics SGMO	A$0.58 M	A$9.74 M	🇺🇸 USA
Charles River Laboratories CRL	A$41.03 M	A$0.11 B	🇺🇸 USA